SK12682003A3 - Prípravky obsahujúce imidazotriazinón na nazálnu aplikáciu - Google Patents

Prípravky obsahujúce imidazotriazinón na nazálnu aplikáciu Download PDF

Info

Publication number
SK12682003A3
SK12682003A3 SK1268-2003A SK12682003A SK12682003A3 SK 12682003 A3 SK12682003 A3 SK 12682003A3 SK 12682003 A SK12682003 A SK 12682003A SK 12682003 A3 SK12682003 A3 SK 12682003A3
Authority
SK
Slovakia
Prior art keywords
group
hydrochloride
carbon atoms
alkyl
optionally
Prior art date
Application number
SK1268-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Peter Serno
Andreas Ohm
Wolfgang Barth
Richard-Josef Bauer
Hans-Martin Siefert
Dieter Zimmer
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of SK12682003A3 publication Critical patent/SK12682003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1268-2003A 2001-04-12 2002-04-03 Prípravky obsahujúce imidazotriazinón na nazálnu aplikáciu SK12682003A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10118306A DE10118306A1 (de) 2001-04-12 2001-04-12 Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation
PCT/EP2002/003663 WO2002083674A2 (de) 2001-04-12 2002-04-03 Imidazotriazinonhaltige zusammensetzungen zur nasalen applikation

Publications (1)

Publication Number Publication Date
SK12682003A3 true SK12682003A3 (sk) 2004-03-02

Family

ID=7681379

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1268-2003A SK12682003A3 (sk) 2001-04-12 2002-04-03 Prípravky obsahujúce imidazotriazinón na nazálnu aplikáciu

Country Status (25)

Country Link
US (2) US6740306B2 (hu)
EP (1) EP1381368A2 (hu)
JP (1) JP2004525968A (hu)
KR (1) KR20030087072A (hu)
CN (1) CN1537004A (hu)
AR (1) AR035821A1 (hu)
BG (1) BG108245A (hu)
BR (1) BR0208813A (hu)
CA (1) CA2443639A1 (hu)
CZ (1) CZ20032752A3 (hu)
DE (1) DE10118306A1 (hu)
DO (1) DOP2002000373A (hu)
EC (1) ECSP034795A (hu)
EE (1) EE200300501A (hu)
GT (1) GT200200070A (hu)
HU (1) HUP0303877A3 (hu)
IL (1) IL158255A0 (hu)
MX (1) MXPA03009314A (hu)
NO (1) NO20034556L (hu)
PE (1) PE20021035A1 (hu)
PL (1) PL363033A1 (hu)
RU (1) RU2003133143A (hu)
SK (1) SK12682003A3 (hu)
UY (1) UY27256A1 (hu)
WO (1) WO2002083674A2 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2278927T3 (es) * 2001-05-09 2007-08-16 Bayer Healthcare Ag Nuevo uso de imidazotriazinonas de 2-(2-etoxi-5-(4-metil-piperazin-1-sulfonil)-fenil)-5-metil-7-propil-3h-imidazo(5,1-f)(1,2,4)triazin-4-ona.
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
SG161208A1 (en) * 2004-12-23 2010-05-27 Roxro Pharma Inc Therapeutic compositions for intranasal administration of ketorolac
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
MX2008000087A (es) * 2005-06-23 2008-03-18 Schering Corp Formulaciones orales rapidamente absorbentes de inhibidores de la fosfodiesterasa 5.
US20090186896A1 (en) * 2005-09-29 2009-07-23 Bayer Healthcare Ag PDE Inhibitors and Combinations Thereof for the Treatment of Urological Disorders
CN101711153A (zh) * 2007-06-13 2010-05-19 拜耳先灵制药股份公司 用于治疗听觉损伤的pde抑制剂
CN102137656A (zh) * 2008-06-13 2011-07-27 罗克斯罗制药公司 用于鼻内投予的酮咯酸医药调配物
US8551454B2 (en) * 2009-03-13 2013-10-08 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
US8277781B2 (en) * 2009-03-13 2012-10-02 Luitpold Pharmaceuticals, Inc. Device for intranasal administration
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2020006606A1 (en) * 2018-07-05 2020-01-09 Helium 3 Resources Pty Ltd A pharmaceutical composition and method of use of same
SE542968C2 (en) * 2018-10-26 2020-09-22 Lindahl Anders Treatment of osteoarthritis
EP4157449A4 (en) * 2020-05-26 2024-05-29 Strategic Drug Solutions, Inc. FORMULATIONS AND METHODS FOR THE TREATMENT OF ERECTILE DYSFUNCTION

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602099A (en) * 1973-04-02 1986-07-22 Merrell Dow Pharmaceuticals Inc. Antirhinovirus agents
GB9013750D0 (en) 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9514465D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9514473D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
EP0985671B1 (en) 1996-05-31 2003-04-02 Mochida Pharmaceutical Co., Ltd. PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT
GB2315673A (en) * 1996-08-01 1998-02-11 Merck & Co Inc Treatment of migraine
EP0992240A4 (en) * 1997-05-29 2003-04-16 Mochida Pharm Co Ltd THERAPEUTIC AGENT FOR TREATING ANERECTION
JP2001517628A (ja) 1997-09-23 2001-10-09 イーライ・リリー・アンド・カンパニー 注意欠陥／多動障害の治療法
ES2386420T3 (es) 1997-11-12 2012-08-20 Bayer Pharma Aktiengesellschaft Imidazotriazinonas sustituidas con fenilo en la posición 2 como inhibidores de fosfodiesterasas
TWI223598B (en) * 1998-06-22 2004-11-11 Pfizer Ireland Pharmaceuticals An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
WO2000000199A1 (en) * 1998-06-26 2000-01-06 Nastech Pharmaceutical Company, Inc. Nasal delivery of sildenafil citrate
KR20010093828A (ko) * 1998-12-14 2001-10-29 셀러지 파마세우티칼스, 인크 항문직장 질환 치료용 조성물 및 치료 방법

Also Published As

Publication number Publication date
PL363033A1 (en) 2004-11-15
DE10118306A1 (de) 2002-10-17
CA2443639A1 (en) 2002-10-24
NO20034556D0 (no) 2003-10-10
EP1381368A2 (de) 2004-01-21
BG108245A (en) 2005-01-31
KR20030087072A (ko) 2003-11-12
UY27256A1 (es) 2002-11-29
US20040248891A1 (en) 2004-12-09
US6740306B2 (en) 2004-05-25
JP2004525968A (ja) 2004-08-26
HUP0303877A3 (en) 2005-05-30
MXPA03009314A (es) 2004-03-10
ECSP034795A (es) 2003-12-01
CZ20032752A3 (cs) 2004-01-14
CN1537004A (zh) 2004-10-13
PE20021035A1 (es) 2002-11-29
WO2002083674A2 (de) 2002-10-24
RU2003133143A (ru) 2005-04-10
US20030022894A1 (en) 2003-01-30
EE200300501A (et) 2003-12-15
GT200200070A (es) 2003-01-31
HUP0303877A2 (hu) 2004-03-29
WO2002083674A3 (de) 2003-01-09
BR0208813A (pt) 2004-03-09
NO20034556L (no) 2003-12-10
IL158255A0 (en) 2004-05-12
DOP2002000373A (es) 2002-11-30
AR035821A1 (es) 2004-07-14

Similar Documents

Publication Publication Date Title
US11717571B2 (en) Intranasal epinephrine formulations and methods for the treatment of disease
AP1178A (en) Intranasal formulations for treating sexual disorders
EP2522365B1 (en) Compositions comprising azelastine and methods of use thereof
SK12682003A3 (sk) Prípravky obsahujúce imidazotriazinón na nazálnu aplikáciu
US20070065366A1 (en) Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation
US7220767B2 (en) Pharmaceutical formulations containing zolmitriptan
KR20020016831A (ko) 비내용 모르핀을 함유하는 의약 조성물 및 그 제조방법
AU2005281736A1 (en) Roflumilast and syk inhibitor combination and methods of use thereof
SK15112002A3 (sk) Liečivo na liečenie sexuálnej dysfunkcie pacienta
US20040142944A1 (en) Compositions for nasal application
JP2011524366A (ja) 鼻内投与のためのケトロラクの薬学的処方物
ES2791775B2 (es) Formulaciones de epinefrina intranasal y metodos para el tratamiento de enfermedades
GB2114001A (en) Nasal pharmaceutical compositions
FI81258C (fi) Foerfarande foer framstaellning av en farmaceutisk komposition foer nasal administration.